Eli Gilboa
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Virology top 0.5%
Papers in
-
- RNA Interference and Gene Delivery 61
- CRISPR and Genetic Engineering 22
- Advanced biosensing and bioanalysis techniques 17
- Immunology 110
- Immunotherapy and Immune Responses 91
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 22
- Co-authors
- Smita K. Nair (34 shared papers)David Boczkowski (25 shared papers)Bruce A. Sullenger (12 shared papers)Johannes Vieweg (19 shared papers)David J. Snyder (6 shared papers)David Baltimore (9 shared papers)Angel Porgador (5 shared papers)H. Kim Lyerly (11 shared papers)
- Journals
- The Journal of Immunology (13 papers)Blood (10 papers)Proceedings of the National Academy of Sciences (9 papers)Journal of Virology (9 papers)Journal of Clinical Investigation (7 papers)
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Eli Gilboa
181 papers receiving 19.1k citations
Eli Gilboa's Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 10.5k
- Virology 1.3k
- Oncology 6.0k
- Genetics 5.0k
- Molecular Biology 11.5k
Countries citing papers authored by Eli Gilboa
This map shows the geographic impact of Eli Gilboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Gilboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Gilboa more than expected).
Fields of papers citing papers by Eli Gilboa
This network shows the impact of papers produced by Eli Gilboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Gilboa. The network helps show where Eli Gilboa may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Gilboa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras Hit paper breakdown → | 2006 | 812 |
| 2 | Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. Hit paper breakdown → | 1996 | 761 |
| 3 | A detailed model of reverse transcription and tests of crucial aspects Hit paper breakdown → | 1979 | 539 |
| 4 | Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. Hit paper breakdown → | 1990 | 511 |
| 5 | Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors Hit paper breakdown → | 1985 | 494 |
| 6 | 2007 | 454 | |
| 7 | 2002 | 419 | |
| 8 | Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA Hit paper breakdown → | 1980 | 418 |
| 9 | 1986 | 409 | |
| 10 | 2002 | 382 | |
| 11 | 1997 | 367 | |
| 12 | 1990 | 361 | |
| 13 | Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. | 1990 | 346 |
| 14 | 1998 | 335 | |
| 15 | 2012 | 331 | |
| 16 | 1995 | 328 | |
| 17 | 1999 | 312 | |
| 18 | 1987 | 310 | |
| 19 | 2000 | 295 | |
| 20 | Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target Hit paper breakdown → | 2018 | 287 |
About Eli Gilboa
Eli Gilboa is a scholar working on Molecular Biology, Immunology, Genetics, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 183 papers that have together received 20.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (91 papers), RNA Interference and Gene Delivery (61 papers), Virus-based gene therapy research (54 papers), Immune Cell Function and Interaction (26 papers), CAR-T cell therapy research (25 papers), T-cell and B-cell Immunology (22 papers), CRISPR and Genetic Engineering (22 papers) and Advanced biosensing and bioanalysis techniques (17 papers). The work is most often cited by research in Immunology (10.5k citations), Virology (1.3k citations), Oncology (6.0k citations), Genetics (5.0k citations) and Molecular Biology (11.5k citations). Eli Gilboa has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Smita K. Nair, David Boczkowski, Bruce A. Sullenger, Johannes Vieweg, David J. Snyder, David Baltimore, Angel Porgador, H. Kim Lyerly, Rajat Bannerji and Stephen P. Goff. Their work appears in journals such as The Journal of Immunology, Blood, Proceedings of the National Academy of Sciences, Journal of Virology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.